Additionally, RBP4, identified as a serum marker for ovarian cancer, directly induces cancer progression of ovarian cancer cells by increasing the expression of the cancer metastasis factors MM2 and MM9 through the RhoA/Rock1 pathway [17,18]. This evidence concerns the gene RBP4 and ovarian carcinoma.